BioCentury
ARTICLE | Company News

St. Jude Children’s Research Hospital, Calimmune deal

January 18, 2016 8:00 AM UTC

St. Jude granted Calimmune exclusive, worldwide rights to develop and commercialize products using a stable packaging cell line that produces lentiviral vectors. Calimmune will use the technology for ...